The primary objective of our study was to reduce nephrotoxicity with the use of low doses of calcineurin inhibitors or sirolimus. Risk factors for calcineurin inhibitor nephrotoxicity after renal transplantation. There is no doubt that acute calcineurin inhibitor cni nephrotoxicity exists. Cytochrome p450 3a5 expression in the kidneys of patients. Immune checkpoint inhibitors icpis have transformed the landscape of oncology, but are associated with a variety of autoimmune adverse events, including aki. Calcineurin inhibitors cnis are both the savior and achilles heel of kidney transplantation.
The many faces of calcineurin inhibitor toxicitywhat the. The beneficial effects are, however, tampered by acute and chronic nephrotoxicity leading to interstitial fibrosis and tubular atrophy, which impairs longterm allograft survival. The examination of the role of intracellular transport proteins drug efflux proteins in modulating calcineurin inhibitor toxicities is appealing given that pglycoprotein pgp is known to transport both ciclosporin and tacrolimus 12. Although cnis remain the most effective available immunosuppressant agent, there is clinical concern regarding possible. The dramatic incidence of chronic kidney disease and even endstage renal disease in patients with heart, liver, and lung transplants supports the. Mechanisms of calcineurin inhibitor nephrotoxicity in. It activates the t cells of the immune system and can be blocked by drugs.
The mineralocorticoid hormone aldosterone induces fibrosis in numerous. The vasoconstrictor impact of cyclosporine csa and to a lesser. There is no doubt that acute calcineurin inhibitor. Calcineurin inhibitor cni nephrotoxicity may occur any time after initiation of therapy, and can affect transplant or native kidneys and present as acute or chronic reductions in kidney function. The use of the calcineurin inhibitors cyclosporine and tacrolimus led to major advances in the field of transplantation, with excellent shortterm outcome. Calcineurin inhibitor cni nephrotoxicity may occur any time after initiation of therapy, and can affect transplant or native kidneys and. Calcineurin inhibitor nephrotoxicity american society of. Because calcineurin inhibitors suppress the immune system they are known as immunosuppressants. It is a poisonous effect of some substances, both toxic chemicals and medications, on kidney function.
Use of the calcineurin inhibitors cni cyclosporine and tacrolimus has revolutionized solid organ transplantation. New insights into calcineurin inhibitor nephrotoxicity jennifer l. By continuing to use our website, you are agreeing to our use of cookies. Calcineurin nephrotoxicity advances in chronic kidney. However, calcineurin and nfat are not tcell specific, and the use of cyclosporine and tacrolimus is associated with toxicity beyond immunosuppression, such as metabolic alterations hyperlipidemia and diabetes mellitus, hypertension, nephrotoxicity, neurotoxicity, and cosmetic changes gingival hypertrophy and hypertrichosis. Calcineurin inhibitors ciclosporin and tacrolimus can cause acute and chronic nephrotoxicity. Investigators continue to explore the aetiologies for calcineurin inhibitorrelated nephrotoxicity 911.
Calcineurin inhibitors have markedly reduced acute rejection rates in renal transplantation, thus significantly improved shortterm outcome. Pathophysiology and treatment of calcineurin inhibitor. Pathophysiology and treatment of calcineurin inhibitor nephrotoxicity jonna kemper, pharmd and kara kniska, pharmd. Although calcineurin inhibitors cnis have significantly improved the outcome for solidorgan transplant recipients, they have drugspecific side effects. It is a cyclic fungal peptide, composed of 11 amino acids.
Calcineurin inhibitors, cyclosporine and tacrolimus, have improved allograft survival in solid organ transplantation. Cni nephrotoxicity is manifested either as acute kidney injury aki, which is largely reversible after reducing the dose, or as chronic progressive renal disease, which is usually irreversible. Calcineurin inhibitor nephrotoxicity free download as pdf file. It is believed that pharmacokinetic and pharmacodynamic interactions are involved and that the major effect is observed in the tissue compartment rather than in the blood,14. Calcineurin inhibitorinduced nephrotoxicity and renal. Jcm free fulltext a low tacrolimus concentrationdose. Topical calcineurin inhibitors are usually prescribed as secondline treatment, which means they are used after primary treatment with topical corticosteroids has already been tried and has not sufficiently improved symptoms of ad. Like tacrolimus, ciclosporin novartis sandimmune is a calcineurin inhibitor cni. Pathophysiology and treatment of calcineurin inhibitor nephrotoxicity.
Kautzner department of cardiology, institute for clinical and experimental medicine, prague, czech republic centre of experimental medicine, institute for clinical and experimental medicine, prague. Chronic calcineurin inhibitor nephrotoxicitylest we forget. These agents are freely filtered by the glomeruli and quickly taken up by the proximal tubular epithelial cells, where they are incorporated into lysosomes after first interacting with phospholipids on the brush border membranes. Full text risk factors for calcineurin inhibitor nephrotoxicity after. Combination of a calcineurin inhibitor and a mammalian. However, the chronic nephrotoxicity of these drugs is the achilles heel of current immunosuppressive regimens. Pathophysiological mechanisms of calcineurin inhibitorinduced nephrotoxicity and arterial hypertension l.
Calcineurin inhibitors are medicines which inhibit the action of calcineurin. Causes of renal failure are varied, including diabetes, hypertension, glomerular and cystic kidney diseases, and autoimmune disorders. Cnis have been strongly associated with hypertension, dyslipidemia, and new onset of. Calcineurin inhibitorinduced nephrotoxicity and renal expression of p. Atlas of renal pathology ii american journal of kidney. Calcineurin inhibitors and nephrotoxicity in children. There are various forms, and some drugs may affect kidney function in more than one way. Susceptibility to calcineurin inhibitor nephrotoxicity cnit after solid organ transplantation could be related to an interindividual variability in renal expression and function of the. Pathophysiological mechanisms of calcineurin inhibitor. Icpiassociated aki icpiaki is emerging as an increasingly frequent cause of aki in patients with cancer, and poses unique diagnostic and management challenges to clinicians who care for these patients. Pdf on feb 10, 2012, craig slattery and others published mechanisms of calcineurin inhibitor nephrotoxicity in chronic allograft injury find, read and cite all the research you need on.
Because of nephrotoxicity, lower doses or temporary withdrawal may be used when calcineurin inhibitors have caused or are likely to cause nephrotoxicity e. Garcia2, yun bai1 1 department of pharmaceutical sciences, school of pharmacy, philadelphia college of osteopathic medicine, suwanee, georgia, united states of america, 2 department of anesthesiology. Cyclosporine a alters expression of renal micrornas. Although cnis remain the most effective available immunosuppressant agent, there is clinical concern regarding possible long. The serum levels of these drugs do not correlate well. One purported side effect is chronic progressive nephrotoxicity, but there are few meaningful data to support this contention. Pdf mechanisms of calcineurin inhibitor nephrotoxicity. Nephrotoxins are substances displaying nephrotoxicity. Calcineurin can is a calcium and calmodulin dependent serinethreonine protein phosphatase also known as protein phosphatase 3, and calciumdependent serinethreonine phosphatase. Cni can cause vasoconstriction and increased serum creatinine scr in. Although marked progression has been made in initial survival rates, longterm kidney graft survival has yet to show such encouraging results. Renal calcineurininhibitor toxicity is a common adverse effect of tacrolimus therapy. Early detection of calcineurin inhibitor nephrotoxicity on biopsy assists in planning maintenance therapy see chapters 97 and 103 chapter 97 chapter 103.
Chronic arteriolopathy a characteristic sign of chronic ci toxicity is the presence of focal or circular lumpy hyaline deposits in the media of afferent arterioles arteriolar hyalinosis which. By 10 years, virtually all allografts will have evidence of cni nephrotoxicity. Kautzner1 1department of cardiology, institute for clinical and experimental medicine, prague, czech republic, 2centre of experimental medicine, institute for clinical and experimental medicine. Ryan 1 and tara mcmorrow 1 1renal disease research group, ucd school of biomolecular and biomedical science ucd conway institute university college dublin. Research article cyclosporine a alters expression of renal micrornas. Reduced exposure to calcineurin inhibitors in renal. Cyclosporine and tacrolimus are immunosuppressive agents used for prophylaxis against graft rejection in transplantation, and are often used off label due to their inhibition of t cell activation in autoimmune. Cyclosporine, a calcineurin inhibitor in use for many years, is still the basis of many immunosuppressive regimens because of its clinical success. Calcineurin is an enzyme that activates tcells of the immune system. It has been in use since 1983 and is one of the most widely used immunosuppressive drugs. Alpers, md2 clinical and pathologic features calcineurin inhibitor cni nephrotoxicity may occur any time after initiation of therapy, and can affect transplant or native kidneys and present as. Calcineurin inhibitor nephrotoxicity american society of nephrology. Cyclosporine and tacrolimus nephrotoxicity uptodate. Everolimus initiation with early calcineurin inhibitor.
Calcineurin activates nuclear factor of activated t cell cytoplasmic, a transcription factor, by dephosphorylating it. Topical calcineurin inhibitors are medications that are applied to the skin that are used in the treatment of eczema, including atopic dermatitis ad. For more than 30 yr, the transplant community has dealt with nephrotoxicity attributed to these agents. Chronic calcineurin inhibitor cni nephrotoxicity has been incriminated in the lack of improvement in longterm kidney allograft survival as it has. Patients treated with the calcineurin inhibitors cnis cyclosporine and tacrolimus are at high risk of developing kidney injury. Calcineurin inhibitors cnis are commonly given to transplant recipients of kidneys and other solid organs and to patients with immune disorders, such as steroidresistant nephrotic syndrome, steroiddependent nephrotic syndrome, and frequent relapse nephrotic syndrome. Calcineurin inhibitor cni nephrotoxicity was recognized in cambridge in the late 1970s. Better insight into the mechanisms underlying calcineurin inhibitor nephrotoxicity. Pathophysiological mechanisms of calcineurin inhibitorinduced nephrotoxicity and arterial hypertension. View the article pdf and any associated supplements and figures for a period of 48 hours.
Calcineurin inhibitor cni immunosuppression has been widely believed to increase the risk for chronic kidney disease ckd after heart transplantation, 2, 7 spawning investigation into various immunosuppressive strategies that minimize cni exposure. Kidney transplantation is the treatment of choice for end stage renal. The present contribution hypothesized that tacrolimusinduced nephrotoxicity is related to a low concentrationdose cd ratio. However, standard recommended doses are associated with nephrotoxicity, resulting in longterm renal dysfunction,2 hypertension, and hyperlipidemia. Calcineurin inhibitor an overview sciencedirect topics. Calcineurin nephrotoxicity is not restricted to kidney grafts, where chronic immunologic damage to the kidney may coexist.
Although cnis have significantly reduced rates of acute rejection, their numerous toxicities can plague kidney transplant recipients. Fast tacrolimus metabolism is linked to inferior outcomes such as rejection and lower renal function after kidney transplantation. Frontiers does mineralocorticoid receptor antagonism. Calcineurin and mtor inhibitor nephrotoxicity 51 this drug combination. Indeed, they have reduced the incidence of acute rejection episodes of cadaveric allograft recipients. Elevated serum cni trough levels may help make the diagnosis, although cni nephrotoxicity is not necessarily dose dependent.
Tcells also called tlymphocytes are a type of white blood cell that play a key role in cellmediated immunity. Acute renal vasoconstriction as described by many investigators, including john curtis and colleagues is the unequivocal consequence of their use. Genomicderived markers for early detection of calcineurin. Accordingly, the primary end point was renal function. Approximately 17,000 kidney transplants occur each year in the united states, accounting for almost 60% of all organ transplants. Calcineurin inhibitor ci therapy has been associated with chronic nephrotoxicity, which limits its longterm utility for suppression of allograft r we use cookies to enhance your experience on our website. Calcineurin inhibitorinduced renal allograft nephrotoxicity 299 hemodynamic changes and direct toxic effect on tubular epithelial cells. Aminoglycosides preferentially affect the proximal tubular cells. Pdf prevention of calcineurin inhibitor nephrotoxicity. Prevention of calcineurin inhibitor nephrotoxicity in renal transplantation.
1406 1177 995 418 827 1276 1444 480 137 199 49 64 1159 1014 342 1170 634 1195 219 657 131 754 966 1030 969 884 1489 1277 151 781 135 717 527 631 205 1191 724 1223 679 16 1163 798 969